Cargando…
Metabolic consequences of recombinant human growth hormone therapy in patients with Turner syndrome
INTRODUCTION: Turner syndrome (TS) predisposes to metabolic complications. Currently, TS patients are treated with recombinant human growth hormone (rGH) as standard therapy. The long-term effect of this therapy on carbohydrate metabolism remains unclear. AIM OF THE STUDY: To assess possible metabol...
Autores principales: | Gnacińska, Maria, Magnuszewska, Hanna, Sworczak, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226455/ https://www.ncbi.nlm.nih.gov/pubmed/36734396 http://dx.doi.org/10.5114/pedm.2022.123204 |
Ejemplares similares
-
Growth hormone improves short stature in children with Shwachman-Diamond syndrome
por: Bogusz-Wójcik, Agnieszka, et al.
Publicado: (2021) -
Clinical evaluation of 31 children with pituitary insufficiency in the course of the pituitary stalk interruption syndrome. The unexpected growth without growth hormone in 2 children
por: Chrzanowska, Joanna A., et al.
Publicado: (2021) -
Factors influencing growth in children with growth hormone deficiency – a case-control study
por: Lohiya, NIkhil, et al.
Publicado: (2021) -
Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?
por: Smyczyńska, Joanna, et al.
Publicado: (2021) -
Metabolic Syndrome in Overweight Or Obese Children and Adolescents Based on Own Material
por: Szabelska-Zakrzewska, Katarzyna, et al.
Publicado: (2019)